• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4164.0
  • ISIN : INE782E01017
1,940.50 4 (0.22%)
  • As on 26 Apr 2025 (EOD)

  • Today’s Low

    1,826.10

  • Today’s High

    2,042.30

  • Open

    1,938.00

  • Perv Close

    1,936.30

  • 52W Low

    1,242.95

  • 52W High

    3,379.00

Key Indicators

  • P/E(TTM)

    55.83

  • Mar.Cap (₹Cr.)

    1,650.76

  • Div & Yield %

    0.31

  • Book Value(₹)

    382.47

  • Debt-Equity Ratio

    0.22

  • AGM Date

    25-Apr-2025

  • EPS

    34.84

  • P/E Ratio

    55.83

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    1,650.76

  • RONW (%)

    7.41

  • ROCE (%)

    8.74

Score Board

  • Equity (₹ in Cr.)

    8.51

  • BV (₹)

    382.50

  • Sales( ₹ in Cr.)

    285.16

  • NP (in Cr.)

    27.14

  • NP Var(%)

    -16.0

  • Div%

    60.0

  • CPS (₹)

    43.40

  • EPS (₹)

    31.90

  • Traded Value (₹ in Lakhs)

    1,654.67

  • 52 Week High

    3,379.00

  • 52 Week Low

    1,242.95

  • Price BSE

    1945.0

  • Price NSE

    1,941.00

  • Market Capital( in Cr.)

    1,654.67

  • P/C Ratio

    44.80

  • P/E Ratio

    61.00

  • Price Vs.BV

    31.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 285.16 254.00 219.35 208.48 169.43 171.19
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 285.16 254.00 219.35 208.48 169.43 171.19
Other Income 4.26 5.32 4.66 1.65 2.93 3.10
Stock Adjustments -10.36 4.77 12.53 -4.01 15.57 7.25
Total Income 279.06 264.09 236.54 206.12 187.93 181.54
EXPENDITURE :            
Raw Materials 89.28 84.65 76.37 49.38 44.81 41.88
Power and Fuel Cost 12.34 9.95 8.74 6.93 7.29 7.08
Employee Cost 56.72 47.92 39.12 33.45 37.16 26.74
Other Manufacturing Expenses 12.00 7.57 6.89 5.46 6.19 10.48
Selling and Administration Expenses 52.74 49.26 34.94 32.24 32.88 22.83
Miscellaneous Expenses 4.37 4.55 5.26 10.28 3.95 1.65
Employee Benefit Expenses 56.72 47.92 39.12 33.45 37.16 26.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 227.45 203.88 171.31 137.74 132.28 110.66
Operating Profit 51.60 60.21 65.23 68.37 55.64 70.86
Interest 5.09 6.50 2.47 3.95 5.03 3.54
Gross Profit 46.51 53.71 62.76 64.42 50.61 67.32
Depreciation 9.78 9.79 9.50 9.63 9.39 7.57
Profit Before Tax 36.73 43.92 53.26 54.79 41.22 59.75
Current Tax 9.64 10.73 14.25 16.37 11.81 15.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.06 0.86 -0.51 -1.48 -1.80 0.66
Reported Net Profit 27.16 32.34 39.52 39.90 31.22 43.85
Extraordinary Items 0.02 0.01 0.09 -3.69 0.38 -0.04
Adjusted Net Profit 27.14 32.33 39.43 43.59 30.84 43.89
Adjustment below Net Profit -0.02 0.11 -0.16 0.21 -1.63 -10.49
P & L Balance brought forward 226.20 202.25 171.40 136.90 113.25 79.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.81 8.51 8.51 5.62 5.96 0.00
P & L Balance carried down 246.53 226.20 202.25 171.40 136.90 113.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 80.00 100.00 100.00 66.00 110.00
Dividend Per Share(Rs) 6.00 8.00 10.00 10.00 6.60 11.00
Earnings Per Share-Unit Curr 31.93 38.02 46.45 46.90 36.70 51.55
Earnings Per Share(Adj)-Unit Curr 31.93 38.02 46.45 46.90 36.70 51.55
Book Value 367.59 343.70 315.54 279.28 238.72 210.93
Book Value(Adj)-Unit Curr 367.59 343.70 315.54 279.28 238.72 210.93

Shareholding Pattern

  • Promoter Group

    53.73%

  • Public Share Holding

    46.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 803,955 803,955.00 803,955 803,955
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 803,955 9.45 803,955 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 336,838 3.96 336,838 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,151 40.32 3,430,151 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,766,989 44.28 3,766,989 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 74,143 0.87 74,143 20
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 139 0.00 139 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,500 0.02 1,500 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 75,782 0.89 75,782 23
2] Non Institution
Bodies Corporate 229,678 2.70 229,677 118
Clearing Members 73 0.00 73 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 517,248 6.08 517,248 386
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 219,320 2.58 219,220 350
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,238,625 14.56 1,238,625 16
Individuals holding nominal share capital up to Rs. 1 lakh 1,538,250 18.08 1,472,088 10,927
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,599 0.03 2,599 2
Others 83,902 0.99 83,902 1
Sub Total 3,860,139 45.38 3,793,876 11,817
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,506,865 100.00 8,440,602 11,853

Company Background

Hester Biosciences LtdPharmaceuticals - Indian - Formulations

  • Hester Biosciences Ltd
  • BSE Code : 4164.0
  • ISIN : INE782E01017

  • Incorporation Year

    1987

  • Registered Office

    1st Flr PushpakPachvati Circle
    Motilal Hirabhai Road, Ahmedabad,
    Gujarat-380006

  • Telephone

    91-079-26445107

  • FAX

    91-079-26445105

  • Chairman

    Bhupendra V Gandhi

  • Managing Director

    Rajiv D Gandhi

  • Company Secretary

  • Auditor

    Chandulal M Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Hester Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hester Bios 1,945.10 289.42 285.16 55.83 8.51
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92